Pathological Fracture
7
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Device Global Registry for the IlluminOss Bone Stabilization System
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
Prospective Evaluation of Therapeutic Combination in Treating Vertebral Compression Fractures
Short Versus Long Intramedullary Nails in the Treatment of Proximal Femur Metastasis.
External Beam Radiation Therapy Post Surgery in Patients With Lower Extremity Bone Metastases Randomized Efficacy Trial
Length of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic Lesion
Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts